This report aims to provide a comprehensive presentation of the global market for Immune Checkpoint Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Checkpoint Agents. This report contains market size and forecasts of Immune Checkpoint Agents in global, including the following market information:
Global Immune Checkpoint Agents Market Revenue, 2018-2023, 2024-2029, $ millions
Global Immune Checkpoint Agents Market Sales, 2018-2023, 2024-2029, K Units
Global top five Immune Checkpoint Agents companies in 2022 %
The global Immune Checkpoint Agents market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Anti-PD-L1 Drug Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Immune Checkpoint Agents include Bristol Myers Squibb, Merck, AstraZeneca and Roche, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC MMG has surveyed the Immune Checkpoint Agents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immune Checkpoint Agents Market, by Type, 2018-2023, 2024-2029 $ Millions & K Units
Global Immune Checkpoint Agents Market Segment Percentages, by Type, 2022 %
Anti-PD-L1 Drug
Anti-PD-1 Drug
CTLA4
Global Immune Checkpoint Agents Market, by Application, 2018-2023, 2024-2029 $ Millions & K Units
Global Immune Checkpoint Agents Market Segment Percentages, by Application, 2022 %
Lung Cancer
Colorectal Cancer
BreastCancer
Prostate Cancer
Melanoma
Blood Cancers
Global Immune Checkpoint Agents Market, By Region and Country, 2018-2023, 2024-2029 $ Millions & K Units
Global Immune Checkpoint Agents Market Segment Percentages, By Region and Country, 2022 %
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immune Checkpoint Agents revenues in global market, 2018-2023 Estimated, $ millions
Key companies Immune Checkpoint Agents revenues share in global market, 2022 %
Key companies Immune Checkpoint Agents sales in global market, 2018-2023 Estimated, K Units
Key companies Immune Checkpoint Agents sales share in global market, 2022 %
Further, the report presents profiles of competitors in the market, key players include:
Bristol Myers Squibb
Merck
AstraZeneca
Roche
Outline of Major Chapters:
Chapter 1: Introduces the definition of Immune Checkpoint Agents, market overview.
Chapter 2: Global Immune Checkpoint Agents market size in revenue and volume.
Chapter 3: Detailed analysis of Immune Checkpoint Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Immune Checkpoint Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Immune Checkpoint Agents capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Immune Checkpoint Agents Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immune Checkpoint Agents Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immune Checkpoint Agents Overall Market Size
2.1 Global Immune Checkpoint Agents Market Size: 2022 VS 2029
2.2 Global Immune Checkpoint Agents Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Immune Checkpoint Agents Sales: 2018-2029
3 Company Landscape
3.1 Top Immune Checkpoint Agents Players in Global Market
3.2 Top Global Immune Checkpoint Agents Companies Ranked by Revenue
3.3 Global Immune Checkpoint Agents Revenue by Companies
3.4 Global Immune Checkpoint Agents Sales by Companies
3.5 Global Immune Checkpoint Agents Price by Manufacturer 2018-2023
3.6 Top 3 and Top 5 Immune Checkpoint Agents Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Immune Checkpoint Agents Product Type
3.8 Tier 1, Tier 2 and Tier 3 Immune Checkpoint Agents Players in Global Market
3.8.1 List of Global Tier 1 Immune Checkpoint Agents Companies
3.8.2 List of Global Tier 2 and Tier 3 Immune Checkpoint Agents Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Immune Checkpoint Agents Market Size Markets, 2022 & 2029
4.1.2 Anti-PD-L1 Drug
4.1.3 Anti-PD-1 Drug
4.1.4 CTLA4
4.2 By Type - Global Immune Checkpoint Agents Revenue & Forecasts
4.2.1 By Type - Global Immune Checkpoint Agents Revenue, 2018-2023
4.2.2 By Type - Global Immune Checkpoint Agents Revenue, 2024-2029
4.2.3 By Type - Global Immune Checkpoint Agents Revenue Market Share, 2018-2029
4.3 By Type - Global Immune Checkpoint Agents Sales & Forecasts
4.3.1 By Type - Global Immune Checkpoint Agents Sales, 2018-2023
4.3.2 By Type - Global Immune Checkpoint Agents Sales, 2024-2029
4.3.3 By Type - Global Immune Checkpoint Agents Sales Market Share, 2018-2029
4.4 By Type - Global Immune Checkpoint Agents Price Manufacturers Selling Prices, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immune Checkpoint Agents Market Size, 2022 & 2029
5.1.2 Lung Cancer
5.1.3 Colorectal Cancer
5.1.4 BreastCancer
5.1.5 Prostate Cancer
5.1.6 Melanoma
5.1.7 Blood Cancers
5.2 By Application - Global Immune Checkpoint Agents Revenue & Forecasts
5.2.1 By Application - Global Immune Checkpoint Agents Revenue, 2018-2023
5.2.2 By Application - Global Immune Checkpoint Agents Revenue, 2024-2029
5.2.3 By Application - Global Immune Checkpoint Agents Revenue Market Share, 2018-2029
5.3 By Application - Global Immune Checkpoint Agents Sales & Forecasts
5.3.1 By Application - Global Immune Checkpoint Agents Sales, 2018-2023
5.3.2 By Application - Global Immune Checkpoint Agents Sales, 2024-2029
5.3.3 By Application - Global Immune Checkpoint Agents Sales Market Share, 2018-2029
5.4 By Application - Global Immune Checkpoint Agents Price Manufacturers Selling Prices, 2018-2029
6 Sights by Region
6.1 By Region - Global Immune Checkpoint Agents Market Size, 2022 & 2029
6.2 By Region - Global Immune Checkpoint Agents Revenue & Forecasts
6.2.1 By Region - Global Immune Checkpoint Agents Revenue, 2018-2023
6.2.2 By Region - Global Immune Checkpoint Agents Revenue, 2024-2029
6.2.3 By Region - Global Immune Checkpoint Agents Revenue Market Share, 2018-2029
6.3 By Region - Global Immune Checkpoint Agents Sales & Forecasts
6.3.1 By Region - Global Immune Checkpoint Agents Sales, 2018-2023
6.3.2 By Region - Global Immune Checkpoint Agents Sales, 2024-2029
6.3.3 By Region - Global Immune Checkpoint Agents Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Immune Checkpoint Agents Revenue, 2018-2029
6.4.2 By Country - North America Immune Checkpoint Agents Sales, 2018-2029
6.4.3 US Immune Checkpoint Agents Market Size, 2018-2029
6.4.4 Canada Immune Checkpoint Agents Market Size, 2018-2029
6.4.5 Mexico Immune Checkpoint Agents Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Immune Checkpoint Agents Revenue, 2018-2029
6.5.2 By Country - Europe Immune Checkpoint Agents Sales, 2018-2029
6.5.3 Germany Immune Checkpoint Agents Market Size, 2018-2029
6.5.4 France Immune Checkpoint Agents Market Size, 2018-2029
6.5.5 U.K. Immune Checkpoint Agents Market Size, 2018-2029
6.5.6 Italy Immune Checkpoint Agents Market Size, 2018-2029
6.5.7 Russia Immune Checkpoint Agents Market Size, 2018-2029
6.5.8 Nordic Countries Immune Checkpoint Agents Market Size, 2018-2029
6.5.9 Benelux Immune Checkpoint Agents Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Immune Checkpoint Agents Revenue, 2018-2029
6.6.2 By Region - Asia Immune Checkpoint Agents Sales, 2018-2029
6.6.3 China Immune Checkpoint Agents Market Size, 2018-2029
6.6.4 Japan Immune Checkpoint Agents Market Size, 2018-2029
6.6.5 South Korea Immune Checkpoint Agents Market Size, 2018-2029
6.6.6 Southeast Asia Immune Checkpoint Agents Market Size, 2018-2029
6.6.7 India Immune Checkpoint Agents Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Immune Checkpoint Agents Revenue, 2018-2029
6.7.2 By Country - South America Immune Checkpoint Agents Sales, 2018-2029
6.7.3 Brazil Immune Checkpoint Agents Market Size, 2018-2029
6.7.4 Argentina Immune Checkpoint Agents Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Immune Checkpoint Agents Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Immune Checkpoint Agents Sales, 2018-2029
6.8.3 Turkey Immune Checkpoint Agents Market Size, 2018-2029
6.8.4 Israel Immune Checkpoint Agents Market Size, 2018-2029
6.8.5 Saudi Arabia Immune Checkpoint Agents Market Size, 2018-2029
6.8.6 UAE Immune Checkpoint Agents Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bristol Myers Squibb
7.1.1 Bristol Myers Squibb Company Summary
7.1.2 Bristol Myers Squibb Business Overview
7.1.3 Bristol Myers Squibb Immune Checkpoint Agents Major Product Offerings
7.1.4 Bristol Myers Squibb Immune Checkpoint Agents Sales and Revenue in Global 2018-2023
7.1.5 Bristol Myers Squibb Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Immune Checkpoint Agents Major Product Offerings
7.2.4 Merck Immune Checkpoint Agents Sales and Revenue in Global 2018-2023
7.2.5 Merck Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Immune Checkpoint Agents Major Product Offerings
7.3.4 AstraZeneca Immune Checkpoint Agents Sales and Revenue in Global 2018-2023
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche Immune Checkpoint Agents Major Product Offerings
7.4.4 Roche Immune Checkpoint Agents Sales and Revenue in Global 2018-2023
7.4.5 Roche Key News & Latest Developments
8 Global Immune Checkpoint Agents Production Capacity, Analysis
8.1 Global Immune Checkpoint Agents Production Capacity, 2018-2029
8.2 Immune Checkpoint Agents Production Capacity of Key Manufacturers in Global Market
8.3 Global Immune Checkpoint Agents Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Immune Checkpoint Agents Supply Chain Analysis
10.1 Immune Checkpoint Agents Industry Value Chain
10.2 Immune Checkpoint Agents Upstream Market
10.3 Immune Checkpoint Agents Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Immune Checkpoint Agents Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Immune Checkpoint Agents in Global Market
Table 2. Top Immune Checkpoint Agents Players in Global Market, Ranking by Revenue 2022
Table 3. Global Immune Checkpoint Agents Revenue by Companies, US$, Mn, 2018-2023
Table 4. Global Immune Checkpoint Agents Revenue Share by Companies, 2018-2023
Table 5. Global Immune Checkpoint Agents Sales by Companies, K Units, 2018-2023
Table 6. Global Immune Checkpoint Agents Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Immune Checkpoint Agents Price 2018-2023 & USD/Unit
Table 8. Global Manufacturers Immune Checkpoint Agents Product Type
Table 9. List of Global Tier 1 Immune Checkpoint Agents Companies, Revenue US$, Mn in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immune Checkpoint Agents Companies, Revenue US$, Mn in 2022 and Market Share
Table 11. By Type ? Global Immune Checkpoint Agents Revenue, US$, Mn, 2022 & 2029
Table 12. By Type - Global Immune Checkpoint Agents Revenue US$, Mn, 2018-2023
Table 13. By Type - Global Immune Checkpoint Agents Revenue US$, Mn, 2024-2029
Table 14. By Type - Global Immune Checkpoint Agents Sales K Units, 2018-2023
Table 15. By Type - Global Immune Checkpoint Agents Sales K Units, 2024-2029
Table 16. By Application ? Global Immune Checkpoint Agents Revenue, US$, Mn, 2022 & 2029
Table 17. By Application - Global Immune Checkpoint Agents Revenue US$, Mn, 2018-2023
Table 18. By Application - Global Immune Checkpoint Agents Revenue US$, Mn, 2024-2029
Table 19. By Application - Global Immune Checkpoint Agents Sales K Units, 2018-2023
Table 20. By Application - Global Immune Checkpoint Agents Sales K Units, 2024-2029
Table 21. By Region ? Global Immune Checkpoint Agents Revenue, US$, Mn, 2022 VS 2029
Table 22. By Region - Global Immune Checkpoint Agents Revenue US$, Mn, 2018-2023
Table 23. By Region - Global Immune Checkpoint Agents Revenue US$, Mn, 2024-2029
Table 24. By Region - Global Immune Checkpoint Agents Sales K Units, 2018-2023
Table 25. By Region - Global Immune Checkpoint Agents Sales K Units, 2024-2029
Table 26. By Country - North America Immune Checkpoint Agents Revenue, US$, Mn, 2018-2023
Table 27. By Country - North America Immune Checkpoint Agents Revenue, US$, Mn, 2024-2029
Table 28. By Country - North America Immune Checkpoint Agents Sales, K Units, 2018-2023
Table 29. By Country - North America Immune Checkpoint Agents Sales, K Units, 2024-2029
Table 30. By Country - Europe Immune Checkpoint Agents Revenue, US$, Mn, 2018-2023
Table 31. By Country - Europe Immune Checkpoint Agents Revenue, US$, Mn, 2024-2029
Table 32. By Country - Europe Immune Checkpoint Agents Sales, K Units, 2018-2023
Table 33. By Country - Europe Immune Checkpoint Agents Sales, K Units, 2024-2029
Table 34. By Region - Asia Immune Checkpoint Agents Revenue, US$, Mn, 2018-2023
Table 35. By Region - Asia Immune Checkpoint Agents Revenue, US$, Mn, 2024-2029
Table 36. By Region - Asia Immune Checkpoint Agents Sales, K Units, 2018-2023
Table 37. By Region - Asia Immune Checkpoint Agents Sales, K Units, 2024-2029
Table 38. By Country - South America Immune Checkpoint Agents Revenue, US$, Mn, 2018-2023
Table 39. By Country - South America Immune Checkpoint Agents Revenue, US$, Mn, 2024-2029
Table 40. By Country - South America Immune Checkpoint Agents Sales, K Units, 2018-2023
Table 41. By Country - South America Immune Checkpoint Agents Sales, K Units, 2024-2029
Table 42. By Country - Middle East & Africa Immune Checkpoint Agents Revenue, US$, Mn, 2018-2023
Table 43. By Country - Middle East & Africa Immune Checkpoint Agents Revenue, US$, Mn, 2024-2029
Table 44. By Country - Middle East & Africa Immune Checkpoint Agents Sales, K Units, 2018-2023
Table 45. By Country - Middle East & Africa Immune Checkpoint Agents Sales, K Units, 2024-2029
Table 46. Bristol Myers Squibb Company Summary
Table 47. Bristol Myers Squibb Immune Checkpoint Agents Product Offerings
Table 48. Bristol Myers Squibb Immune Checkpoint Agents Sales K Units, Revenue US$, Mn and Average Price USD/Unit 2018-2023
Table 49. Bristol Myers Squibb Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Immune Checkpoint Agents Product Offerings
Table 52. Merck Immune Checkpoint Agents Sales K Units, Revenue US$, Mn and Average Price USD/Unit 2018-2023
Table 53. Merck Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Immune Checkpoint Agents Product Offerings
Table 56. AstraZeneca Immune Checkpoint Agents Sales K Units, Revenue US$, Mn and Average Price USD/Unit 2018-2023
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Roche Company Summary
Table 59. Roche Immune Checkpoint Agents Product Offerings
Table 60. Roche Immune Checkpoint Agents Sales K Units, Revenue US$, Mn and Average Price USD/Unit 2018-2023
Table 61. Roche Key News & Latest Developments
Table 62. Immune Checkpoint Agents Production Capacity K Units of Key Manufacturers in Global Market, 2021-2023 K Units
Table 63. Global Immune Checkpoint Agents Capacity Market Share of Key Manufacturers, 2021-2023
Table 64. Global Immune Checkpoint Agents Production by Region, 2018-2023 K Units
Table 65. Global Immune Checkpoint Agents Production by Region, 2024-2029 K Units
Table 66. Immune Checkpoint Agents Market Opportunities & Trends in Global Market
Table 67. Immune Checkpoint Agents Market Drivers in Global Market
Table 68. Immune Checkpoint Agents Market Restraints in Global Market
Table 69. Immune Checkpoint Agents Raw Materials
Table 70. Immune Checkpoint Agents Raw Materials Suppliers in Global Market
Table 71. Typical Immune Checkpoint Agents Downstream
Table 72. Immune Checkpoint Agents Downstream Clients in Global Market
Table 73. Immune Checkpoint Agents Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Immune Checkpoint Agents Segment by Type in 2022
Figure 2. Immune Checkpoint Agents Segment by Application in 2022
Figure 3. Global Immune Checkpoint Agents Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Immune Checkpoint Agents Market Size: 2022 VS 2029 US$, Mn
Figure 6. Global Immune Checkpoint Agents Revenue, 2018-2029 US$, Mn
Figure 7. Immune Checkpoint Agents Sales in Global Market: 2018-2029 K Units
Figure 8. The Top 3 and 5 Players Market Share by Immune Checkpoint Agents Revenue in 2022
Figure 9. By Type - Global Immune Checkpoint Agents Revenue, US$, Mn, 2022 & 2029
Figure 10. By Type - Global Immune Checkpoint Agents Revenue Market Share, 2018-2029
Figure 11. By Type - Global Immune Checkpoint Agents Sales Market Share, 2018-2029
Figure 12. By Type - Global Immune Checkpoint Agents Price USD/Unit, 2018-2029
Figure 13. By Application - Global Immune Checkpoint Agents Revenue, US$, Mn, 2022 & 2029
Figure 14. By Application - Global Immune Checkpoint Agents Revenue Market Share, 2018-2029
Figure 15. By Application - Global Immune Checkpoint Agents Sales Market Share, 2018-2029
Figure 16. By Application - Global Immune Checkpoint Agents Price USD/Unit, 2018-2029
Figure 17. By Region - Global Immune Checkpoint Agents Revenue, US$, Mn, 2022 & 2029
Figure 18. By Region - Global Immune Checkpoint Agents Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Immune Checkpoint Agents Revenue Market Share, 2018-2029
Figure 20. By Region - Global Immune Checkpoint Agents Sales Market Share, 2018-2029
Figure 21. By Country - North America Immune Checkpoint Agents Revenue Market Share, 2018-2029
Figure 22. By Country - North America Immune Checkpoint Agents Sales Market Share, 2018-2029
Figure 23. US Immune Checkpoint Agents Revenue, US$, Mn, 2018-2029
Figure 24. Canada Immune Checkpoint Agents Revenue, US$, Mn, 2018-2029
Figure 25. Mexico Immune Checkpoint Agents Revenue, US$, Mn, 2018-2029
Figure 26. By Country - Europe Immune Checkpoint Agents Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Immune Checkpoint Agents Sales Market Share, 2018-2029
Figure 28. Germany Immune Checkpoint Agents Revenue, US$, Mn, 2018-2029
Figure 29. France Immune Checkpoint Agents Revenue, US$, Mn, 2018-2029
Figure 30. U.K. Immune Checkpoint Agents Revenue, US$, Mn, 2018-2029
Figure 31. Italy Immune Checkpoint Agents Revenue, US$, Mn, 2018-2029
Figure 32. Russia Immune Checkpoint Agents Revenue, US$, Mn, 2018-2029
Figure 33. Nordic Countries Immune Checkpoint Agents Revenue, US$, Mn, 2018-2029
Figure 34. Benelux Immune Checkpoint Agents Revenue, US$, Mn, 2018-2029
Figure 35. By Region - Asia Immune Checkpoint Agents Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Immune Checkpoint Agents Sales Market Share, 2018-2029
Figure 37. China Immune Checkpoint Agents Revenue, US$, Mn, 2018-2029
Figure 38. Japan Immune Checkpoint Agents Revenue, US$, Mn, 2018-2029
Figure 39. South Korea Immune Checkpoint Agents Revenue, US$, Mn, 2018-2029
Figure 40. Southeast Asia Immune Checkpoint Agents Revenue, US$, Mn, 2018-2029
Figure 41. India Immune Checkpoint Agents Revenue, US$, Mn, 2018-2029
Figure 42. By Country - South America Immune Checkpoint Agents Revenue Market Share, 2018-2029
Figure 43. By Country - South America Immune Checkpoint Agents Sales Market Share, 2018-2029
Figure 44. Brazil Immune Checkpoint Agents Revenue, US$, Mn, 2018-2029
Figure 45. Argentina Immune Checkpoint Agents Revenue, US$, Mn, 2018-2029
Figure 46. By Country - Middle East & Africa Immune Checkpoint Agents Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Immune Checkpoint Agents Sales Market Share, 2018-2029
Figure 48. Turkey Immune Checkpoint Agents Revenue, US$, Mn, 2018-2029
Figure 49. Israel Immune Checkpoint Agents Revenue, US$, Mn, 2018-2029
Figure 50. Saudi Arabia Immune Checkpoint Agents Revenue, US$, Mn, 2018-2029
Figure 51. UAE Immune Checkpoint Agents Revenue, US$, Mn, 2018-2029
Figure 52. Global Immune Checkpoint Agents Production Capacity K Units, 2018-2029
Figure 53. The Percentage of Production Immune Checkpoint Agents by Region, 2022 VS 2029
Figure 54. Immune Checkpoint Agents Industry Value Chain
Figure 55. Marketing Channels
